Cargando…
Prionoids in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is the third most frequent neurodegenerative disease after Alzheimer’s and Parkinson’s disease. ALS is characterized by the selective and progressive loss of motoneurons in the spinal cord, brainstem and cerebral cortex. Clinical manifestations typically occur in...
Autores principales: | Gosset, Philippe, Camu, William, Raoul, Cedric, Mezghrani, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242622/ https://www.ncbi.nlm.nih.gov/pubmed/35783556 http://dx.doi.org/10.1093/braincomms/fcac145 |
Ejemplares similares
-
How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis
por: Crabé, Roxane, et al.
Publicado: (2020) -
Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis
por: Bowerman, Melissa, et al.
Publicado: (2013) -
Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster
por: Layalle, Sophie, et al.
Publicado: (2021) -
Prions, prion-like prionoids, and neurodegenerative disorders
por: Verma, Ashok
Publicado: (2016) -
Dietary BMAA Exposure in an Amyotrophic Lateral Sclerosis Cluster from Southern France
por: Masseret, Estelle, et al.
Publicado: (2013)